For example, although we found that DCs loaded with whole tumor cells are not efficient in cross-presenting MUC-1, a recent study [31] demonstrated that loading DCs with breast cancer cell lysates permits more efficient priming of MUC-1 specific CD8+ T cells. This evidence concerns the gene CD8A and breast carcinoma.